DOCSLIB.ORG

Antigen Presentation Autophagy and Its Role in MHC-Mediated

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Antigen Presentation Autophagy and Its Role in MHC-Mediated Autophagy and Its Role in MHC-Mediated Antigen Presentation Victoria L. Crotzer and Janice S. Blum This information is current as J Immunol 2009; 182:3335-3341; ; of October 2, 2021. doi: 10.4049/jimmunol.0803458 http://www.jimmunol.org/content/182/6/3335 References This article cites 75 articles, 23 of which you can access for free at: Downloaded from http://www.jimmunol.org/content/182/6/3335.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision http://www.jimmunol.org/ • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on October 2, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Autophagy and Its Role in MHC-Mediated Antigen Presentation1 Victoria L. Crotzer and Janice S. Blum2 Intracellular degradation by autophagy plays a role in hydrolase sorting in yeast (6). Another pathway, xenophagy, in- the maintenance of cellular homeostasis under normal volves the use of the autophagic machinery for the degradation conditions and during periods of cellular stress. Auto- of intracellular pathogens (7). Macroautophagy and CMA have phagy has also been implicated in several other cellular been implicated in the presentation of Ag by MHC molecules processes including immune recognition and respon- and, thus, are the major focus of this review. siveness. More specifically, autophagy has been identi- Macroautophagy is also a constitutively active cellular process modulating the degradation of long-lived proteins and or- fied as a route by which cytoplasmic and nuclear Ag are Downloaded from ganelles (1). During short periods of nutrient deprivation, this delivered to MHC class II molecules for presentation to ؉ pathway is rapidly induced as a mechanism to salvage amino CD4 T cells. Autophagy has also recently been impli- acids. The absence of growth factors or amino acids prevents cated in MHC class I cross-presentation of tumor Ag -؉ signaling through PI3K from activating the autophagy regula and the activation of CD8 T cells. This review dis- tory molecule known as mammalian target of rapamycin cusses the role of autophagy in modulating MHC class (mTOR), and thus, macroautophagy is induced (8). In macro- I and class II Ag presentation as well as its implication autophagy, portions of the cytoplasm are sequestered into dou- http://www.jimmunol.org/ in regulating autoimmunity and tolerance, tumor ble-membrane structures known as autophagosomes. The immunity, and host defense against intracellular formation of the autophagosome requires a number of autoph- pathogens. The Journal of Immunology, 2009, 182: agy-related gene (Atg) products that have been well-character- 3335–3341. ized in yeast (6) and are conserved in mammals; the specific details of autophagosome formation have been reviewed exten- sively elsewhere (2, 8). Briefly, the Atg12-Atg5-Atg16 complex, utophagy is one mechanism that cells use to degrade in conjunction with Atg9, mediates the induction of autopha- cytoplasmic proteins and organelles during the main- gosome formation. During this process, LC3 (Atg8) is conju- by guest on October 2, 2021 A tenance of cellular homeostasis (1). There are multi- gated to phosphatidylethanolamine with the assistance of the ple pathways of autophagy. In microautophagy, small portions Atg4, Atg7, and Atg3 molecules and incorporated into the au- of the cytosol are internalized via lysosomal membrane invagi- tophagosomal membrane. This membrane next expands and nations, and proteins are continuously degraded in the lumen engulfs portions of the cytosol, including entire organelles. of this organelle even under resting conditions (2). Microauto- Upon formation of the autophagosome, the Atg12-Atg5-Atg16 phagy is up-regulated under conditions of cellular stress such as complex dissociates from this structure while LC3 (Atg8)-phos- nutrient deprivation, but studies of this pathway have been lim- phatidylethanolamine remains in the autophagic lumen as an ited to yeast and cell-free systems (3, 4). In mammalian cells, autophagosomal marker. The outer membrane of the autopha- constitutively active autophagy pathways can also be up-regu- gosome fuses with the lysosomal membrane, forming an autoly- lated as a mechanism to salvage amino acids during periods of sosome within which the single membrane structure, or auto- cellular stress. Several types of selective autophagy have been phagic body, is degraded by lysosomal esterases, lipases, and identified in mammalian cells including macroautophagy and proteases. chaperone-mediated autophagy (CMA)3 (Fig. 1), as well as During periods of prolonged cellular stress, bulk autophagy pexophagy and mitophagy (5). A related constitutive biosyn- declines, and the process of CMA is up-regulated. In CMA, spe- thetic pathway, cytoplasm-to-vacuole targeting, is involved in cific cytosolic proteins displaying homologous pentapeptide Department of Microbiology and Immunology and the Walther Oncology Center, Indi- 3 Abbreviations used in this paper: CMA, chaperone-mediated autophagy; ALIS, ag- ana University School of Medicine and the Walther Cancer Institute, Indianapolis, IN gresome-like induced structures; Atg, autophagy-related gene; cTEC, cortical thymic 46202 epithelial cell; DC, dendritic cell; EBNA, EBV nuclear Ag; ER, endoplasmic reticu- lum; GAD, glutamic acid decarboxylase; hsc70, heat shock cognate 70-kDa protein; Ii, Received for publication December 19, 2008. Accepted for publication January 21, 2009. invariant chain; LAMP, lysosome-associated membrane protein; 3-MA, 3-methylad- The costs of publication of this article were defrayed in part by the payment of page charges. enine; MP1, influenza matrix protein 1; mTOR, mammalian target of rapamycin; This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. siRNA, small interfering RNA. Section 1734 solely to indicate this fact. Copyright © 2009 by The American Association of Immunologists, Inc. 0022-1767/09/$2.00 1 V.L.C. is supported by a Career Development Award from the Melanoma Research Foundation. National Institutes of Health AI49589 supported the effort of J.S.B. 2 Address correspondence and reprint requests to Dr. Janice S. Blum, Medical Science Building Room 420, 635 Barnhill Drive, Indianapolis, Indiana, 46202-5120. E-mail ad- dress: [email protected] www.jimmunol.org/cgi/doi/10.4049/jimmunol.0803458 3336 BRIEF REVIEWS: AUTOPHAGY AND ANTIGEN PRESENTATION class I presentation pathway is still under investigation, al- though several routes have recently been proposed. These path- ways have been described extensively elsewhere (11–13); thus, only a brief summary of the current models of class I-mediated cross-presentation is offered here. Studies have suggested that MHC class I molecules may ac- quire peptides derived from exogenous Ag internalized into phagosomes in a TAP-dependent or TAP-independent man- ner. In the TAP-dependent phagosome-to-cytosol-to-phago- some pathway, Ag is transported to the cytosol by a yet un- known mechanism, possibly Sec61, and degraded by the proteasome. Peptides are then reimported into the phagosome, FIGURE 1. Pathways of autophagy in MHC class II-mediated Ag presen- which has acquired TAP as well as other ER proteins such as tation. In macroautophagy, the cytoplasm is sequestered into double-mem- MHC class I. The phagosome-to-cytosol pathway calls for pep- brane structures known as autophagosomes, which fuse with lysosomes. In tides generated in the cytosol by the proteasome to be directly CMA, specific cytosolic proteins are transported into lysosomes via a molecular transported to MHC class I molecules in the ER via TAP. An- chaperone/receptor complex composed of hsc70 and LAMP-2A. other possible mechanism of class I-restricted cross-presenta- tion may involve the ER-associated degradation pathway. Here, exogenous Ag internalized in endosomes is transported into the Downloaded from motifs bind to a molecular chaperone complex composed of ER, translocated for degradation in the cytosol by the protea- multiple heat shock proteins including the heat shock cognate some, and finally transported back into the ER by TAP. It has 70-kDa protein (hsc70) (reviewed in Ref. 9). This molecular also been reported that DC may acquire exogenous peptides ϩ chaperone complex transports the substrate protein to the lyso- from other cells via gap junctions to cross-prime naive CD8 T somal membrane, where it associates with an isoform of the ly- cells. Lastly, in the vacuolar pathway, MHC class I molecules http://www.jimmunol.org/ sosome-associated membrane protein (LAMP) 2A, which func- may acquire peptides that are generated in phagosomes by cys- tions as part of the lysosomal receptor for CMA. The teine proteases such as cathepsin S in a TAP-independent man- cytoplasmic domain of LAMP-2A serves as a potential docking ner. The mechanisms that potentiate MHC class I peptide load-
Load more

Recommended publications
  • Natural Killer Cells Associated with SARS-Cov-2 Viral RNA Shedding
    Bao et al. Exp Hematol Oncol (2021) 10:5 https://doi.org/10.1186/s40164-021-00199-1 Experimental Hematology & Oncology LETTER TO THE EDITOR Open Access Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients Changqian Bao1†, Xiandong Tao2,3†, Wei Cui4†, Yuanyuan Hao1, Shuaike Zheng5, Bin Yi2,3, Tiewen Pan2, Ken H. Young6* and Wenbin Qian1,7* Abstract Coronavirus disease 2019 (COVID-19) is a novel infectious viral disease caused by the severe acute respiratory syn- drome coronavirus 2 (SARS-CoV-2). Two consecutively negative SARS-CoV-2 viral RNA test ( interval 24 hours), improved respiratory symptoms and obvious absorption of infammation in pulmonary imaging are≥ the discharge criteria for COVID-19 patients. The clearance profle of viral RNA in the upper respiratory tract specimens, including nasopharyngeal swab and/or oropharyngeal swabs, is related to innate immune cells such as Natural Killer cells. A total of 168 patients were included for the study. In this cohort, non-severe and severe groups showed signifcant dif- ferences in white blood cells, neutrophils, lymphocytes, basophils and platelets counts, as well as in infection related parameters such as CRP and serum cytokine IL-6. For lymphocyte subsets tests at admission, the severe group dis- played signifcantly lower cell counts than the non-severe group. Higher counts of total T cells, CD4 T cells, CD8 T cells, and NK cells in peripheral blood showed a signifcant correlation with the shorter time taken to+ obtain the frst+ negative viral RNA test and frst positive IgM/ IgG antibody test.
    [Show full text]
  • Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases
    antibodies Review Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases Courtney A. Iberg and Daniel Hawiger * Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Doisy Research Center, 1205 Carr Lane, St. Louis, MO 63104, USA; [email protected] * Correspondence: [email protected] Received: 31 March 2020; Accepted: 30 April 2020; Published: 15 June 2020 Abstract: The specific targeting of dendritic cells (DCs) using antigen-delivering antibodies has been established to be a highly efficient protocol for the induction of tolerance and protection from autoimmune processes in experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS), as well as in some other animal disease models. As the specific mechanisms of such induced tolerance are being investigated, the newly gained insights may also possibly help to design effective treatments for patients. Here we review approaches applied for the amelioration of autoimmunity in animal models based on antibody-mediated targeting of self-antigens to DCs. Further, we discuss relevant mechanisms of immunological tolerance that underlie such approaches, and we also offer some future perspectives for the application of similar methods in certain related disease settings such as transplantation. Keywords: dendritic cells; tolerance; antigen targeting; chimeric antibodies; autoimmunity; multiple sclerosis; diabetes 1. Introduction Over one hundred years ago, Paul Ehrlich coined the term “horror autotoxicus” to define an immune attack against an organism’s healthy tissues [1]. Since then, our knowledge of the complex mechanisms of the immune system as well as our understanding of the pathogenesis of specific autoimmune diseases have grown tremendously.
    [Show full text]
  • Adaptive Immune Systems
    Immunology 101 (for the Non-Immunologist) Abhinav Deol, MD Assistant Professor of Oncology Wayne State University/ Karmanos Cancer Institute, Detroit MI Presentation originally prepared and presented by Stephen Shiao MD, PhD Department of Radiation Oncology Cedars-Sinai Medical Center Disclosures Bristol-Myers Squibb – Contracted Research What is the immune system? A network of proteins, cells, tissues and organs all coordinated for one purpose: to defend one organism from another It is an infinitely adaptable system to combat the complex and endless variety of pathogens it must address Outline Structure of the immune system Anatomy of an immune response Role of the immune system in disease: infection, cancer and autoimmunity Organs of the Immune System Major organs of the immune system 1. Bone marrow – production of immune cells 2. Thymus – education of immune cells 3. Lymph Nodes – where an immune response is produced 4. Spleen – dual role for immune responses (especially antibody production) and cell recycling Origins of the Immune System B-Cell B-Cell Self-Renewing Common Progenitor Natural Killer Lymphoid Cell Progenitor Thymic T-Cell Selection Hematopoetic T-Cell Stem Cell Progenitor Dendritic Cell Myeloid Progenitor Granulocyte/M Macrophage onocyte Progenitor The Immune Response: The Art of War “Know your enemy and know yourself and you can fight a hundred battles without disaster.” -Sun Tzu, The Art of War Immunity: Two Systems and Their Key Players Adaptive Immunity Innate Immunity Dendritic cells (DC) B cells Phagocytes (Macrophages, Neutrophils) Natural Killer (NK) Cells T cells Dendritic Cells: “Commanders-in-Chief” • Function: Serve as the gateway between the innate and adaptive immune systems.
    [Show full text]
  • What You Need to Know About Innate Immunity
    WhatWhat youyou needneed toto knowknow aboutabout innateinnate immunityimmunity JenniferJennifer KoKo MD,MD, PhDPhD ClevelandCleveland ClinicClinic Immunology/PathologyImmunology/Pathology andand LaboratoryLaboratory MedicineMedicine InnateInnate ImmunityImmunity FirstFirst lineline ofof defense,defense, immediateimmediate defensedefense DayDay toto dayday protectionprotection OnlyOnly whenwhen innateinnate defensedefense bypassed,bypassed, evadedevaded oror overwhelmedoverwhelmed isis adaptiveadaptive immunityimmunity requiredrequired NonNon--specificspecific RecognizeRecognize pathogenspathogens inin aa genericgeneric wayway DoesDoes notnot conferconfer longlong lastinglasting oror protectiveprotective immunityimmunity toto hosthost EvolutionarilyEvolutionarily older,older, foundfound inin primitiveprimitive organismsorganisms InnateInnate ImmunityImmunity andand InflammationInflammation 1)1) RespondRespond rapidlyrapidly toto tissuetissue damagedamage physicalphysical andand chemicalchemical barrierbarrier recruitmentrecruitment ofof immuneimmune cellscells toto sitesite ofof injuryinjury 2)2) LimitLimit spreadspread ofof infectioninfection identificationidentification andand removalremoval ofof foreignforeign substancessubstances activationactivation ofof thethe complementcomplement cascadecascade activationactivation ofof coagulationcoagulation cascadecascade 3)3) InitiateInitiate adaptiveadaptive immuneimmune responseresponse antigenantigen presentationpresentation andand cytokinecytokine productionproduction 4)4)
    [Show full text]
  • Immunology 101
    Immunology 101 Justin Kline, M.D. Assistant Professor of Medicine Section of Hematology/Oncology Committee on Immunology University of Chicago Medicine Disclosures • I served as a consultant on Advisory Boards for Merck and Seattle Genetics. • I will discuss non-FDA-approved therapies for cancer 2 Outline • Innate and adaptive immune systems – brief intro • How immune responses against cancer are generated • Cancer antigens in the era of cancer exome sequencing • Dendritic cells • T cells • Cancer immune evasion • Cancer immunotherapies – brief intro 3 The immune system • Evolved to provide protection against invasive pathogens • Consists of a variety of cells and proteins whose purpose is to generate immune responses against micro-organisms • The immune system is “educated” to attack foreign invaders, but at the same time, leave healthy, self-tissues unharmed • The immune system can sometimes recognize and kill cancer cells • 2 main branches • Innate immune system – Initial responders • Adaptive immune system – Tailored attack 4 The immune system – a division of labor Innate immune system • Initial recognition of non-self (i.e. infection, cancer) • Comprised of cells (granulocytes, monocytes, dendritic cells and NK cells) and proteins (complement) • Recognizes non-self via receptors that “see” microbial structures (cell wall components, DNA, RNA) • Pattern recognition receptors (PRRs) • Necessary for priming adaptive immune responses 5 The immune system – a division of labor Adaptive immune system • Provides nearly unlimited diversity of receptors to protect the host from infection • B cells and T cells • Have unique receptors generated during development • B cells produce antibodies which help fight infection • T cells patrol for infected or cancerous cells • Recognize “foreign” or abnormal proteins on the cell surface • 100,000,000 unique T cells are present in all of us • Retains “memory” against infections and in some cases, cancer.
    [Show full text]
  • Could Antigen Presenting Cells Represent a Protective Element During SARS-Cov-2 Infection in Children?
    pathogens Review Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children? Rita Lauro 1 , Natasha Irrera 1 , Ali H. Eid 2,3,* and Alessandra Bitto 1,* 1 Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy; [email protected] (R.L.); [email protected] (N.I.) 2 Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar 3 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar * Correspondence: [email protected] (A.H.E.); [email protected] (A.B.) Abstract: Antigen Presenting Cells (APC) are immune cells that recognize, process, and present antigens to lymphocytes. APCs are among the earliest immune responders against an antigen. Thus, in patients with COVID-19, a disease caused by the newly reported SARS-CoV-2 virus, the role of APCs becomes increasingly important. In this paper, we dissect the role of these cells in the fight against SARS-CoV-2. Interestingly, this virus appears to cause a higher mortality among adults than children. This may suggest that the immune system, particularly APCs, of children may be different from that of adults, which may then explain differences in immune responses between these two populations, evident as different pathological outcome. However, the underlying molecular mechanisms that differentiate juvenile from other APCs are not well understood. Whether juvenile APCs are one reason why children are less susceptible to SARS-CoV-2 requires much attention. Citation: Lauro, R.; Irrera, N.; Eid, The goal of this review is to examine the role of APCs, both in adults and children.
    [Show full text]
  • 4. MHC & Antigen Presentation
    4. MHC & Antigen Presentation Background The MHC molecules are glycoproteins encoded in a large cluster of genes located on chromosome 6. They were first identified by their potent effect on the immune response to transplanted tissue (see later). For that reason, the gene complex was termed the ‘‘major histocompatibility complex.’’ MHC genes (called the H-2 complex in mice) were first recognized in 1937 as a barrier to transplantation in mice. In humans, these genes are often called human leukocyte antigens (HLA), as they were first discovered through antigenic differences between white blood cells from different individuals. MHC is the term for the region located on the short arm of chromosome 6p21.31 in humans and chromosome 17 in mice. In humans, it contains more than 200 genes (Figure 1). Figure 1. Genetic map of the MHC regions. This map has been simplified to demonstrate organizational themes within the MHC. There are more than 200 genes within these regions. [Bellanti, JA (Ed). Immunology IV: Clinical Applications in Health and Disease. I Care Press, Bethesda, MD, 2012] The principal function of the MHC is to present antigen to T cells to discriminate between self Immunopaedia.org.za (our cells and tissues) and nonself (the invaders or modified self). Two main characteristics of the MHC make it difficult for pathogens to evade immune responses: First, the MHC is polygenic. It contains several different MHC-I and MHC-II genes so that every individual possesses a set of MHC molecules with different ranges of peptide- binding specificities. Second, the MHC is extremely polymorphic.
    [Show full text]
  • Antigen Presentation by Dendritic Cells for B Cell Activation
    Available online at www.sciencedirect.com ScienceDirect Antigen presentation by dendritic cells for B cell activation 1,2 1,2,4 1,2 William R Heath , Yu Kato , Thiago M Steiner and 3 Irina Caminschi B cells are efficiently activated by antigens presented on cell processes. To tailor effective antibody responses, germinal membranes, which provide opportunity for receptor cross- center (GC) reactions are evoked upon initial pathogen linking and antigen capture. The two main cell types implicated encounter, promoting B cell somatic hypermutation and in native antigen presentation to B cells are follicular dendritic isotype switching, eventually yielding long-term, high + cells (FDC), which reside in B cell follicles, and CD169 affinity, antibody-producing plasma cells of the appropriate macrophages, which line the antigen-exposed surfaces of isotype. Because of their potential to cause pathology to the these follicles in both the lymph nodes and the spleen. There is host, antibody production must be carefully regulated, mounting evidence, however, that conventional dendritic cells especially during GC reactions, where somatic hypermuta- (cDC) can also participate in native antigen presentation to tion has the capacity to generate new specificities, poten- B cells. This underappreciated role, largely hidden by the tially against self. One important control mechanism here is simultaneous need for cDC to participate in T cells priming, the B cells requirement for T cell help. Because T cells are appears to be primarily mediated by the type 2 subset of cDC rendered tolerant to self during thymic selection, specifi- (cDC2), but may also be a function of cDC1. Better cities for self are rare and, as a consequence, so is help for B understanding of how cDC participate in B cell priming is likely cells that mutate to autoreactive specificities.
    [Show full text]
  • Cellular Immunology Targeting Antigen Presentation in Autoimmunity
    Cellular Immunology 339 (2019) 4–9 Contents lists available at ScienceDirect Cellular Immunology journal homepage: www.elsevier.com/locate/ycimm ☆ Targeting antigen presentation in autoimmunity T ⁎ Jason R. Leesa, a Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States ARTICLE INFO ABSTRACT Keywords: Autoimmune diseases are heterogeneous group of disorders that together represent an enormous societal and Antigen presentation medical problem. CD4+ T cells have critical roles in the initiation and pathogenesis of autoimmune disease. As Autoimmunity such, modulation of T cell activity has proven to have significant therapeutic effects in multiple autoimmune fl In ammation settings. T cell activation is a complex process with multiple potential therapeutic targets, many of which have Immune regulation been successfully utilized to treat human disease. Current pharmacological treatment largely targets T cell in- trinsic activities as a means of treating various autoimmune disorders. Here I review extant and potential therapeutic approaches that instead specifically target antigen presentation to CD4+ T cells as a critical checkpoint in autoimmune responses. In addition, the contribution of antigen modulation components in current therapeutic approaches is considered along with the impact of new antigen targeted treatment modalities. Finally, potential challenges are considered in the context of the potential for antigen specific targeting of the antigen presentation process. 1. Introduction responses. Antigen specific modulation of autoimmunity is a highly sought goal, as it would allow therapeutic approaches that would not Although the exact number of disorders that can be considered hinder immune reactivity to pathogens, preventing many of the adverse autoimmune diseases remains an area of contention, dozens of dis- effects that limit current immune modulatory approaches to treatment orders are recognized as including a self-directed adaptive immune of autoimmunity.
    [Show full text]
  • Antigen Presentation : Influence of Cell Type and Route of Antigen Uptake Alice O
    Rockefeller University Digital Commons @ RU Student Theses and Dissertations 2011 Antigen presentation : Influence of Cell Type and Route of Antigen Uptake Alice O. Kamphorst Follow this and additional works at: http://digitalcommons.rockefeller.edu/ student_theses_and_dissertations Part of the Life Sciences Commons Recommended Citation Kamphorst, Alice O., "Antigen presentation : Influence of Cell Type and Route of Antigen Uptake" (2011). Student Theses and Dissertations. Paper 181. This Thesis is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Student Theses and Dissertations by an authorized administrator of Digital Commons @ RU. For more information, please contact [email protected]. ANTIGEN PRESENTATION: INFLUENCE OF CELL TYPE AND ROUTE OF ANTIGEN UPTAKE A Thesis Presented to the Faculty of The Rockefeller University in Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy By Alice O. Kamphorst June 2011 © Copyright by Alice O. Kamphorst 2011 ANTIGEN PRESENTATION: INFLUENCE OF CELL TYPE AND ROUTE OF ANTIGEN UPTAKE Alice O. Kamphorst, Ph.D. The Rockefeller University 2011 Dendritic cells (DCs), which maintain tolerance and orchestrate T cell immune responses, comprise a heterogeneous group of cells. For example, in the steady state, murine spleen contains pre-DC-derived CD8+DEC-205+ and CD8-DCIR2+ conventional DCs. To examine antigen processing and presentation in vivo, antigens were specifically targeted to CD8+ and CD8- DCs using chimeric monoclonal antibodies. We find that CD8- DCs are better than CD8- DCs for presentation of exogenous antigens onto major histocompatibility complex (MHC) class II molecules due to cell intrinsic differences.
    [Show full text]
  • Autophagy in Dendritic Cells
    OPEN Cellular and Molecular Immunology (2018) 15, 944–952 www.nature.com/cmi REVIEW Autophagy in dendritic cells Ghita Ghislat and Toby Lawrence Autophagy and immunity share the property of being auto-protective for the organism. Autophagy is an important degradation pathway that buffers nutrient deprivation by recycling macromolecules in organisms from yeast to man. Perturbations in autophagy are associated with inflammation and cancer development. Emerging studies have characterized the molecular details regarding how autophagy is controlled by immune cells. Among these, dendritic cells (DCs) are one of the most potent professional antigen-presenting cells critical for the activation of naïve T cells to maintain immune tolerance and drive protective immunity to infection and cancer. DCs undergo functional maturation that can either lead to an immunostimulatory phenotype, as in the context of infection, or to a tolerogenic phenotype associated with immunosuppression to self-antigens, as well as to cancer. An increasing number of recent studies has characterized the involvement of autophagy in DC functions in various physiological and pathological contexts. Here, we provide a comprehensive review of these outcomes and discuss the limitation of the models used and the forefront of the knowledge concerning the crosstalk between autophagy and DC biology. Cellular and Molecular Immunology advance online publication, 26 March 2018; doi:10.1038/cmi.2018.2 Keywords: autophagy; dendritic cells; maturation INTRODUCTION components by lysosomes through various modifications on Dendritic cells (DCs) are professional antigen-presenting cells their membranes; (ii) chaperone-mediated autophagy by which critical for the interdependence between the innate and proteins holding KFERQ-like motifs translocate into the adaptive immune systems.
    [Show full text]
  • MHC Class II Super-Enhancer Increases Surface Expression of HLA-DR and HLA-DQ and Affects Cytokine Production in Autoimmune Vitiligo
    MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo Giulio Cavallia,b,1, Masahiro Hayashic, Ying Jinc,d, Daniel Yorgovd, Stephanie A. Santoricoc,e, Cherie Holcombf, Melinda Rastrouf, Henry Erlichf, Isak W. Tengesdala, Lorenzo Dagnab, C. Preston Neffa, Brent E. Palmera, Richard A. Spritzc,d, and Charles A. Dinarelloa,g,1 aDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO 80045; bInternal Medicine and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Raffaele Scientific Institute and Vita-Salute San Raffaele University, 20132 Milan, Italy; cHuman Medical Genetics and Genomics Program, University of Colorado School of Medicine, Aurora, CO 80045; dDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045; eDepartment of Mathematical & Statistical Science, University of Colorado Denver, Denver, CO 80217; fDepartment of Human Genetics, Roche Molecular Systems, Pleasanton, CA 94588; and gDepartment of Medicine, Radboud University Medical Center, HB6500 Nijmegen, The Netherlands Contributed by Charles A. Dinarello, December 6, 2015 (sent for review November 2, 2015; reviewed by Betty Diamond and Robert D. Nicholls) Genetic risk for autoimmunity in HLA genes is most often attributed with 27 different loci (4–6), most strongly with MHC class II region to structural specificity resulting in presentation of self-antigens. Au- SNPs in the vicinity of the HLA-DRB1 and HLA-DQA1 genes. toimmune vitiligo is strongly associated with the MHC class II region. Here, we refine genetic mapping of vitiligo risk in the MHC class II Here, we fine-map vitiligo MHC class II genetic risk to three SNPs only region to a haplotype of three SNPs that span just 47 nucleotides 47 bp apart, located within a predicted super-enhancer in an intergenic between HLA-DRB1 and HLA-DQA1, carried on an HLA-DR53 region between HLA-DRB1 and HLA-DQA1, localized by a genome- haplotype.
    [Show full text]